138 related articles for article (PubMed ID: 20576277)
1. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease.
Forlenza OV; Torres CA; Talib LL; de Paula VJ; Joaquim HP; Diniz BS; Gattaz WF
J Psychiatr Res; 2011 Feb; 45(2):220-4. PubMed ID: 20576277
[TBL] [Abstract][Full Text] [Related]
2. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients.
Talib LL; Hototian SR; Joaquim HP; Forlenza OV; Gattaz WF
Eur Arch Psychiatry Clin Neurosci; 2015 Dec; 265(8):701-6. PubMed ID: 25920742
[TBL] [Abstract][Full Text] [Related]
3. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression.
Joaquim HP; Talib LL; Forlenza OV; Diniz BS; Gattaz WF
J Psychiatr Res; 2012 Aug; 46(8):1053-8. PubMed ID: 22622071
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
5. Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?
Diniz BS; Talib LL; Joaquim HP; de Paula VR; Gattaz WF; Forlenza OV
World J Biol Psychiatry; 2011 Apr; 12(3):216-22. PubMed ID: 21314327
[TBL] [Abstract][Full Text] [Related]
6. Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment.
Gattaz WF; Forlenza OV; Talib LL; Barbosa NR; Bottino CM
J Neural Transm (Vienna); 2004 May; 111(5):591-601. PubMed ID: 15088152
[TBL] [Abstract][Full Text] [Related]
7. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.
Pláteník J; Fišar Z; Buchal R; Jirák R; Kitzlerová E; Zvěřová M; Raboch J
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():83-93. PubMed ID: 24334212
[TBL] [Abstract][Full Text] [Related]
8. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
Zhao S; Zhao J; Zhang T; Guo C
Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
[TBL] [Abstract][Full Text] [Related]
9. Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease.
Castri P; Iacovelli L; De Blasi A; Giubilei F; Moretti A; Tari Capone F; Nicoletti F; Orzi F
Eur J Neurosci; 2007 Nov; 26(9):2469-72. PubMed ID: 17986027
[TBL] [Abstract][Full Text] [Related]
10. Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease.
Wang RT; Jin D; Li Y; Liang QC
J Psychiatr Res; 2013 May; 47(5):644-9. PubMed ID: 23395109
[TBL] [Abstract][Full Text] [Related]
11. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P
Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
13. Platelet tau pattern correlates with cognitive status in Alzheimer's disease.
Farías G; Pérez P; Slachevsky A; Maccioni RB
J Alzheimers Dis; 2012; 31(1):65-9. PubMed ID: 22495344
[TBL] [Abstract][Full Text] [Related]
14. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
[TBL] [Abstract][Full Text] [Related]
15. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease.
Hye A; Kerr F; Archer N; Foy C; Poppe M; Brown R; Hamilton G; Powell J; Anderton B; Lovestone S
Neurosci Lett; 2005 Jan; 373(1):1-4. PubMed ID: 15555766
[TBL] [Abstract][Full Text] [Related]
17. Glycogen-synthase kinase-3beta is decreased in peripheral blood mononuclear cells of patients with mild cognitive impairment.
Marksteiner J; Humpel C
Exp Gerontol; 2009; 44(6-7):370-1. PubMed ID: 19249342
[TBL] [Abstract][Full Text] [Related]
18. Association of GSK3B with Alzheimer disease and frontotemporal dementia.
Schaffer BA; Bertram L; Miller BL; Mullin K; Weintraub S; Johnson N; Bigio EH; Mesulam M; Wiedau-Pazos M; Jackson GR; Cummings JL; Cantor RM; Levey AI; Tanzi RE; Geschwind DH
Arch Neurol; 2008 Oct; 65(10):1368-74. PubMed ID: 18852354
[TBL] [Abstract][Full Text] [Related]
19. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.
Kwok JB; Loy CT; Hamilton G; Lau E; Hallupp M; Williams J; Owen MJ; Broe GA; Tang N; Lam L; Powell JF; Lovestone S; Schofield PR
Ann Neurol; 2008 Oct; 64(4):446-54. PubMed ID: 18991351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
